Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Sang Kyu Cho"'
Autor:
Vaishnavi Tata, Randa Al Saadi, Sang Kyu Cho, Tyler J. Varisco, Matthew Wanat, J. Douglas Thornton
Publikováno v:
BMC Health Services Research, Vol 23, Iss 1, Pp 1-13 (2023)
Abstract Objective To understand the physician perspective on the barriers and facilitators of implementing nine different opioid risk mitigation strategies (RMS) when prescribing opioid medications. Methods We created and dispersed a cross-sectional
Externí odkaz:
https://doaj.org/article/ad99587219a04f7b871c92ccc60d0189
Publikováno v:
Annals of Geriatric Medicine and Research, Vol 25, Iss 1, Pp 33-38 (2021)
Background With the rapid demographic change in Korea, Alzheimer’s disease has become a primary concern. Recent developments in disease-modifying therapies provide hope that therapy may become available soon. The high disease prevalence and complex
Externí odkaz:
https://doaj.org/article/11dee7cb6c544de6856d551f431d8ed3
Publikováno v:
Diabetes Epidemiology and Management, Vol 6, Iss , Pp 100070- (2022)
Aims: To evaluate the prevalence and risk factors of diabetic eye complications among the United States (US) adults and examine the differences across racial and ethnic groups. Methods: Using the 2009–2018 Medical Expenditures Panel Survey (MEPS) d
Externí odkaz:
https://doaj.org/article/f1a4901e1f6e4ab3843637002c72964d
Publikováno v:
Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, Vol 13, Iss 1, Pp n/a-n/a (2021)
Abstract Introduction The approval of a disease‐modifying Alzheimer's disease (AD) treatment could provide relief to US state budgets that were hit hard by the COVID‐19 pandemic, as mostly Medicare would cover treatment cost, whereas Medicaid wou
Externí odkaz:
https://doaj.org/article/04c7d0671c1f4e90a131bde9ca8e77b5
Publikováno v:
Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, Vol 12, Iss 1, Pp n/a-n/a (2020)
Abstract Introduction Concerns have been raised about the limited health system capacity for identification of patients who are eligible for a disease‐modifying Alzheimer's treatment (DMT). Blood‐based biomarker (BBBM) tests are a promising tool
Externí odkaz:
https://doaj.org/article/dc075dfa27cb4adeb28a23088e4dc767
Autor:
Douglas Thornton, Tyler J. Varisco, Marc L. Fleming, Hua Chen, Sang Kyu Cho, Douglas Ziedonis, Susan Abughosh
Publikováno v:
Journal of the American Pharmacists Association. 61:589-595
Background Not all pharmacies stock and dispense buprenorphine, potentially complicating continuous access to care for patients with opioid use disorder (OUD). This may become problematic if a patient’s primary pharmacy can no longer provide bupren
Publikováno v:
Annals of Geriatric Medicine and Research
Annals of Geriatric Medicine and Research, Vol 25, Iss 1, Pp 33-38 (2021)
Annals of Geriatric Medicine and Research, Vol 25, Iss 1, Pp 33-38 (2021)
Background With the rapid demographic change in Korea, Alzheimer's disease has become a primary concern. Recent developments in disease-modifying therapies provide hope that therapy may become available soon. The high disease prevalence and complex e
Publikováno v:
The American journal of managed care. 28(4)
To evaluate the association between clinics' wound healing performance and clinic-level measures of care continuity, clinical quality, and sociodemographic characteristics of the population in their catchment areas.In this cross-sectional analysis, w
Autor:
Scott J. Johnson, Sang Kyu Cho, Suchin Virabhak, Beenish S Manzoor, Sheila Shapouri, Simon Sharmokh, Arliene Ravelo, Kavita Sail, Tatyana Kapustyan, H. Parisé, Matthew S. Davids
Publikováno v:
PharmacoEconomics. 38:941-951
This study aimed to assess the total cost of care (TCC) and budget impact of introducing 12-month fixed duration venetoclax + obinutuzumab (VEN+G) as first-line treatment for chronic lymphocytic leukemia (CLL) from the perspective of a US health plan
Autor:
Hankyung Jun, Sang Kyu Cho
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN. 19(3)